Joined as the Chief Executive Officer in 2014. The company was originally founded to develop medical device blood cards and methods and is successfully producing that product today. He has co-founded five analytical science companies.

He has co-authored 306 peer-reviewed publications in the fields of chromatography, proteomics, and metabolomcs and holds 47 patents in analytical and diagnostic science.

Currently an Associate Professor at Department of Biochemistry at University of Nebraska – Lincoln. He also serves as a Director of Proteomics and Metabolomics Core Facilities at Redox Biology Center at UNL.

Dr. Adamec has co-authored more than 60 peer reviewed publications and serves as a reviewer of Science and journals. Many of his publications focus on proteomic and metabolomics approaches to Systems Biology.

Founding partner of Novilytic, and has operational responsibility for, design implementation and manufacturing activities associated with the Noviplex product-line.

As Director of Operations, and later as President of Chematics, Incorporated., Mr. Woenker has over 30 years of broad experience in the design and manufacture, registration and approval of a variety of disposable Class I and II in-vitro diagnostic medical devices.

Has over 20 years of experience in the start-up, marketing, and management of companies that provide software and instruments to the pharmaceutical and government sectors.  He started his career as a chemist and product development manager, eventually working his way into the management field on an international basis.  Paul has held equity positions in various successful exits.